Prevalence
Causes
Clinical
features
Differential
Diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Prevention |
Give elderly patients
b
and patients with lung disease
d
-
influenza vaccine (preferably combined live and inactivated)
a
Why?
-
It reduces pneumonia, hospital admissions and death in elderly patients.
b
-
It causes few side effects, except sore arms.
a
Influenza vaccination reduces pneumonia, hospital admissions and death
| Patient |
Treatment |
Comparison |
Outcome |
CER |
OR (95% CI) |
NNT
(95% CI) |
elderly
b
|
influenza vaccine
|
placebo
|
pneumonia
|
1.3%
|
0.47 (0.34 to
0.65) |
150
(120 to
220)
|
|
|
|
|
hospitalisation
|
0.79%
|
0.50 (0.35 to
0.72) |
260
(200 to
460)
|
|
|
|
|
death
|
1.0%
|
0.32 (0.24 to
0.44) |
140
(130 to
170)
|
Intramusuclar influenza vaccination causes sore arms
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
elderly outpatient
a
|
influenza vaccine intramuscularly
|
placebo intramuscularly
|
sore arm
at
|
4.8%
|
-330%
(-620% to
-150%)
|
-6
(-9 to
-5)
|
-
Elderly patients who receive combined live and inactivated influenza A vaccines are less likely to develop influenza A, without clearly having more adverse side-effects
a
Combined live and inactivated vaccines reduce influenza more than inactivated alone
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
elderly in long-term care facility
a
|
combined live and inactivated vaccine
|
inactivated vaccine
|
laboratory-documented influenza A
at
3
years
|
14%
|
61%
(18% to
81%)
|
12
(7 to
43)
|
|